Close Menu

NEW YORK (GenomeWeb) – Laboratory Corporation of America said today that its pending acquisition of Sequenom has passed antitrust review.

Expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 satisfies one of the conditions needed to complete the acquisition.

In July, LabCorp said it planned to acquire Sequenom for $302 million in cash, or $2.40 per share, in a deal it expected to close by the end of the year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.